STOCKHOLM, Jan. 7, 2020 /PRNewswire/ -- Oncopeptides AB
(Nasdaq Stockholm: ONCO) announced today that Karin Eklund Vanderpol has been appointed as
head of regulatory affairs of Oncopeptides. Karin has 20 years of
experience from senior positions in regulatory affairs. Prior to
joining Oncopeptides, she served as Global Regulatory Director at
Swedish Orphan Biovitrum. She will be a member Oncopeptides'
Management Team and will start today. Elisabeth Augustsson, who has been responsible
for Oncopeptides' regulatory function since 2015 will continue in a
senior role in the regulatory team.
For more information, please contact:
Jakob Lindberg
CEO of Oncopeptides
E-mail: jakob.lindberg@oncopeptides.com
Telephone: +46-8-615-20-40
Rein Piir
Head of Investor Relations at Oncopeptides
E-mail: rein.piir@oncopeptides.com
Cell phone: +46-70-853-72-92
This information was submitted for publication at 08.00 CET
January 7, 2020.
About Oncopeptides
Oncopeptides is a pharmaceutical company focused on the
development of targeted therapies for difficult-to-treat
hematological diseases. The company is focusing on the development
of the lead product candidate melflufen, a novel peptide-drug
conjugate that rapidly delivers a cytotoxic payload into tumor
cells. Melflufen is in development as a new treatment for the
hematological cancer multiple myeloma and is currently being tested
in multiple clinical studies including the pivotal phase 2 HORIZON
study and the ongoing phase 3 OCEAN study. Oncopeptides'
headquarters is in Stockholm,
Sweden, and the company is listed in the Mid Cap segment on
Nasdaq Stockholm with the ticker ONCO.
More information is available on www.oncopeptides.com.
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/oncopeptides-ab/r/oncopeptides-strengthens-its-regulatory-function-by-appointing-karin-eklund-vanderpol-as-head-of-reg,c3002258
The following files are available for download:
https://mb.cision.com/Main/15404/3002258/1170538.pdf
|
Press Release - New
Head of Regulatory January 7, 2020
|
View original
content:http://www.prnewswire.com/news-releases/oncopeptides-strengthens-its-regulatory-function-by-appointing-karin-eklund-vanderpol-as-head-of-regulatory-affairs-300982348.html
SOURCE Oncopeptides AB